organization · Reporting owner
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Silver Point Specialty Lending FundN/A · Entity 43278 | 10% owner | May 01, 2026 | May 29, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Silver Point Specialty Lending Fund
Report date May 01, 2026 · Filed May 29, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| COMMON SHARESSEC Table I · non-derivative | Direct | 4,283,063.6581 |
Reported balance
After 2026-05-01 transaction · row 1
1 source rowRow 1 · 2026-05-01 · Purchase · Acquired 47,481.3571 · Balance 4,283,063.6581 F1: Shares acquired pursuant to a capital call under the issuer partnership agreement. Capital call occurred on 05.01.2026 and the confirmation of shares and share price occurred on 05.28.2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares acquired pursuant to a capital call under the issuer partnership agreement. Capital call occurred on 05.01.2026 and the confirmation of shares and share price occurred on 05.28.2026.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Rein Therapeutics, Inc.
Report date June 14, 2024 · Filed June 17, 2024
Section 16 reporting ended · disclosed 2024-06-17. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,746,549 |
Last balance in matching sequence
After 2024-06-17 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2024-06-14 · Sale · Disposed 1,900 · Balance 1,751,256 F1: Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the "Regents"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents. Row 2 · 2024-06-17 · Sale · Disposed 4,707 · Balance 1,746,549 F1: Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the "Regents"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the "Regents"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 01, 2026 Filed May 29, 2026 19:37 UTC | Silver Point Specialty Lending Fund N/A · Entity 43278 | PurchaseCOMMON SHARES | 47,481.3571 | $27.36 | $1,299,089.93 |
DisclosureSEC source: 0001019231-26-000019 · primary_doc.xml · nonDerivative · entry 1 UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO · CIK 0001019231 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,283,063.6581 F1 · deemedExecutionDate: Shares acquired pursuant to a capital call under the issuer partnership agreement. Capital call occurred on 05.01.2026 and the confirmation of shares and share price occurred on 05.28.2026. Read SEC document |
| April 01, 2026 Filed Apr 30, 2026 17:21 UTC | Silver Point Specialty Lending Fund N/A · Entity 43278 | PurchaseCOMMON SHARES | 86,674.6407 | $27.47 | $2,380,952.38 |
DisclosureSEC source: 0001019231-26-000014 · primary_doc.xml · nonDerivative · entry 1 UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO · CIK 0001019231 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,235,582.301 F1 · deemedExecutionDate: Shares acquired pursuant to a capital call under the issuer partnership agreement. Capital call occurred on 04.01.2026 and the confirmation of shares and share price occurred on 04.29.2026. Issuer provided notice of confirmation statement on 04.29.2026. Read SEC document |
| March 02, 2026 Filed Apr 1, 2026 17:01 UTC | Silver Point Specialty Lending Fund N/A · Entity 43278 | PurchaseCOMMON SHARES | 170,984.0129 | $27.85 | $4,761,904.76 |
DisclosureSEC source: 0001019231-26-000013 · primary_doc.xml · nonDerivative · entry 1 UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO · CIK 0001019231 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,148,907.6603 F1 · deemedExecutionDate: Shares acquired pursuant to a capital call under the issuer partnership agreement. Capital call occurred on 03.02.2026 and the confirmation of shares and share price occurred on 03.30.2026. Issuer provided notice of confirmation statement on 03.31.2026. Read SEC document |
| February 02, 2026 Filed Mar 2, 2026 22:12 UTC | Silver Point Specialty Lending Fund N/A · Entity 43278 | PurchaseCOMMON SHARES | 245,231.474 | $27.93 | $6,849,315.07 |
DisclosureSEC source: 0001019231-26-000012 · primary_doc.xml · nonDerivative · entry 1 UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO · CIK 0001019231 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,977,923.6474 F1 · deemedExecutionDate: Shares acquired pursuant to a capital call under the issuer partnership agreement. Capital call occurred on 02.02.2026 and the confirmation of shares and share price occurred on 02.26.2026. Issuer provided notice of confirmation statement on 03.02.2026. Read SEC document |
| January 02, 2026 Filed Feb 2, 2026 20:21 UTC | Silver Point Specialty Lending Fund N/A · Entity 43278 | PurchaseCOMMON SHARES | 347,236.6903 | $27.96 | $9,708,737.86 |
DisclosureSEC source: 0001019231-26-000001 · primary_doc.xml · nonDerivative · entry 1 UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO · CIK 0001019231 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,732,692.1734 F1 · deemedExecutionDate: Shares acquired pursuant to a capital call under the issuer partnership agreement. Capital call occurred on 01.02.2026 and the confirmation of shares and share price occurred on 01.30.2026. F2 · balance_after: The difference in the reported number of shares from the prior Form 4 filing reflects the issuer reverse stock split at a ratio of one for two, effective 12.26.2025. The reverse stock split was intended to be treated as a recapitalization, with no gain or loss recognized by shareholders. Read SEC document |
| December 01, 2025 Filed Dec 29, 2025 22:26 UTC | Silver Point Specialty Lending Fund N/A · Entity 43278 | PurchaseCOMMON SHARES | 609,115.652 | $14.12 | $8,600,713.01 |
DisclosureSEC source: 0001019231-25-000013 · primary_doc.xml · nonDerivative · entry 1 UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO · CIK 0001019231 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,770,910.966 F1 · deemedExecutionDate: 1. Shares acquired pursuant to a capital call under the issuer partnership agreement. Capital call occurred on 12.01.2025 and the confirmation of shares and share price occurred on 12.29.2025. Read SEC document |
| November 01, 2025 Filed Nov 26, 2025 21:54 UTC | Silver Point Specialty Lending Fund N/A · Entity 43278 | PurchaseCOMMON SHARES | 622,251.721 | $14.18 | $8,823,529.40 |
DisclosureSEC source: 0001019231-25-000012 · primary_doc.xml · nonDerivative · entry 1 UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO · CIK 0001019231 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,161,795.314 F1 · deemedExecutionDate: Shares acquired pursuant to a capital call under the issuer partnership agreement. Capital call occurred on 11.01.2025 and the confirmation of shares and share price occurred on 11.18.2025. Issuer provided notice of confirmation statement on 11.26.2025. Read SEC document |
| October 01, 2025 Filed Oct 28, 2025 00:34 UTC | Silver Point Specialty Lending Fund N/A · Entity 43278 | PurchaseCommon Stock | 534,633.563 | $14.17 | $7,575,757.59 |
DisclosureSEC source: 0001193125-25-251957 · ownership.xml · nonDerivative · entry 1 UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO · CIK 0001019231 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,539,543.593 Read SEC document |
| June 17, 2024 Filed Jun 17, 2024 23:03 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | SaleCommon Stock | 4,707 | $3.25 | $15,297.75 |
DisclosureSEC source: 0001019231-24-000026 · primary_doc.xml · nonDerivative · entry 2 UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO · CIK 0001019231 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,746,549 F1 · ownership.direct: Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the "Regents"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents. Read SEC document |
| June 14, 2024 Filed Jun 17, 2024 23:03 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | SaleCommon Stock | 1,900 | $3.30 | $6,270.00 |
DisclosureSEC source: 0001019231-24-000026 · primary_doc.xml · nonDerivative · entry 1 UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO · CIK 0001019231 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,751,256 F1 · ownership.direct: Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the "Regents"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents. Read SEC document |
| June 12, 2024 Filed Jun 12, 2024 22:18 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | SaleCommon Stock | 1 | $3.28 | $3.28 |
DisclosureSEC source: 0001019231-24-000025 · primary_doc.xml · nonDerivative · entry 5 UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO · CIK 0001019231 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,753,156 F1 · ownership.direct: Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the "Regents"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents. Read SEC document |
| June 12, 2024 Filed Jun 12, 2024 22:18 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | SaleCommon Stock | 9,341 | $3.25 | $30,358.25 |
DisclosureSEC source: 0001019231-24-000025 · primary_doc.xml · nonDerivative · entry 4 UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO · CIK 0001019231 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,753,157 F1 · ownership.direct: Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the "Regents"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents. Read SEC document |
| June 11, 2024 Filed Jun 12, 2024 22:18 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | SaleCommon Stock | 502 | $3.35 | $1,681.70 |
DisclosureSEC source: 0001019231-24-000025 · primary_doc.xml · nonDerivative · entry 3 UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO · CIK 0001019231 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,762,498 F1 · ownership.direct: Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the "Regents"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents. Read SEC document |
| June 11, 2024 Filed Jun 12, 2024 22:18 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | SaleCommon Stock | 5,250 | $3.25 | $17,062.50 |
DisclosureSEC source: 0001019231-24-000025 · primary_doc.xml · nonDerivative · entry 2 UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO · CIK 0001019231 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,763,000 F1 · ownership.direct: Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the "Regents"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents. Read SEC document |
| June 10, 2024 Filed Jun 12, 2024 22:18 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | SaleCommon Stock | 9,577 | $3.30 | $31,604.10 |
DisclosureSEC source: 0001019231-24-000025 · primary_doc.xml · nonDerivative · entry 1 UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO · CIK 0001019231 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,768,250 F1 · ownership.direct: Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the "Regents"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents. Read SEC document |
| June 07, 2024 Filed Jun 7, 2024 22:59 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | SaleCommon Stock | 176 | $3.30 | $580.80 |
DisclosureSEC source: 0001019231-24-000024 · primary_doc.xml · nonDerivative · entry 5 UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO · CIK 0001019231 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,777,827 F1 · ownership.direct: Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the "Regents"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents. Read SEC document |
| June 07, 2024 Filed Jun 7, 2024 22:59 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | SaleCommon Stock | 1,564 | $3.25 | $5,083.00 |
DisclosureSEC source: 0001019231-24-000024 · primary_doc.xml · nonDerivative · entry 4 UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO · CIK 0001019231 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,778,003 F1 · ownership.direct: Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the "Regents"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents. Read SEC document |
| June 06, 2024 Filed Jun 7, 2024 22:59 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | SaleCommon Stock | 3,184 | $3.30 | $10,507.20 |
DisclosureSEC source: 0001019231-24-000024 · primary_doc.xml · nonDerivative · entry 3 UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO · CIK 0001019231 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,779,567 F1 · ownership.direct: Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the "Regents"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents. Read SEC document |
| June 06, 2024 Filed Jun 7, 2024 22:59 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | SaleCommon Stock | 1,100 | $3.27 | $3,597.00 |
DisclosureSEC source: 0001019231-24-000024 · primary_doc.xml · nonDerivative · entry 2 UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO · CIK 0001019231 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,782,751 F1 · ownership.direct: Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the "Regents"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents. Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 22:59 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | SaleCommon Stock | 6,291 | $3.30 | $20,760.30 |
DisclosureSEC source: 0001019231-24-000024 · primary_doc.xml · nonDerivative · entry 1 UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO · CIK 0001019231 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,783,851 F1 · ownership.direct: Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the "Regents"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents. Read SEC document |
| May 01, 2024 Filed May 1, 2024 23:15 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | SaleCommon Stock | 25 | $4.32 | $108.00 |
DisclosureSEC source: 0001019231-24-000022 · primary_doc.xml · nonDerivative · entry 24 UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO · CIK 0001019231 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,779,306 F1 · ownership.direct: Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the "Regents"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents. Read SEC document |
| May 01, 2024 Filed May 1, 2024 23:15 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | SaleCommon Stock | 2,903 | $4.29 | $12,453.87 |
DisclosureSEC source: 0001019231-24-000022 · primary_doc.xml · nonDerivative · entry 23 UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO · CIK 0001019231 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,779,331 F1 · ownership.direct: Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the "Regents"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents. Read SEC document |
| May 01, 2024 Filed May 1, 2024 23:15 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | SaleCommon Stock | 200 | $4.29 | $857.00 |
DisclosureSEC source: 0001019231-24-000022 · primary_doc.xml · nonDerivative · entry 22 UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO · CIK 0001019231 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,782,234 F1 · ownership.direct: Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the "Regents"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents. Read SEC document |
| May 01, 2024 Filed May 1, 2024 23:15 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | SaleCommon Stock | 337 | $4.28 | $1,442.36 |
DisclosureSEC source: 0001019231-24-000022 · primary_doc.xml · nonDerivative · entry 21 UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO · CIK 0001019231 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,782,434 F1 · ownership.direct: Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the "Regents"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents. Read SEC document |
| May 01, 2024 Filed May 1, 2024 23:15 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | SaleCommon Stock | 200 | $4.28 | $855.00 |
DisclosureSEC source: 0001019231-24-000022 · primary_doc.xml · nonDerivative · entry 20 UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO · CIK 0001019231 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,782,771 F1 · ownership.direct: Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the "Regents"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents. Read SEC document |
| May 01, 2024 Filed May 1, 2024 23:15 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | SaleCommon Stock | 100 | $4.27 | $427.00 |
DisclosureSEC source: 0001019231-24-000022 · primary_doc.xml · nonDerivative · entry 19 UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO · CIK 0001019231 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,782,971 F1 · ownership.direct: Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the "Regents"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents. Read SEC document |
| May 01, 2024 Filed May 1, 2024 23:15 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | SaleCommon Stock | 317 | $4.27 | $1,352.01 |
DisclosureSEC source: 0001019231-24-000022 · primary_doc.xml · nonDerivative · entry 18 UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO · CIK 0001019231 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,783,071 F1 · ownership.direct: Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the "Regents"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents. Read SEC document |
| May 01, 2024 Filed May 1, 2024 23:15 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | SaleCommon Stock | 310 | $4.26 | $1,320.60 |
DisclosureSEC source: 0001019231-24-000022 · primary_doc.xml · nonDerivative · entry 17 UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO · CIK 0001019231 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,783,388 F1 · ownership.direct: Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the "Regents"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents. Read SEC document |
| May 01, 2024 Filed May 1, 2024 23:15 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | SaleCommon Stock | 7,923 | $4.25 | $33,672.75 |
DisclosureSEC source: 0001019231-24-000022 · primary_doc.xml · nonDerivative · entry 16 UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO · CIK 0001019231 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,783,698 F1 · ownership.direct: Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the "Regents"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents. Read SEC document |
| May 01, 2024 Filed May 1, 2024 23:15 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | SaleCommon Stock | 400 | $4.18 | $1,672.00 |
DisclosureSEC source: 0001019231-24-000022 · primary_doc.xml · nonDerivative · entry 15 UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO · CIK 0001019231 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,791,621 F1 · ownership.direct: Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the "Regents"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents. Read SEC document |
| May 01, 2024 Filed May 1, 2024 23:15 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | SaleCommon Stock | 670 | $4.15 | $2,780.50 |
DisclosureSEC source: 0001019231-24-000022 · primary_doc.xml · nonDerivative · entry 14 UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO · CIK 0001019231 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,792,021 F1 · ownership.direct: Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the "Regents"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents. Read SEC document |
| May 01, 2024 Filed May 1, 2024 23:15 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | SaleCommon Stock | 1,600 | $4.15 | $6,632.00 |
DisclosureSEC source: 0001019231-24-000022 · primary_doc.xml · nonDerivative · entry 13 UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO · CIK 0001019231 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,792,691 F1 · ownership.direct: Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the "Regents"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents. Read SEC document |
| May 01, 2024 Filed May 1, 2024 23:15 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | SaleCommon Stock | 380 | $4.13 | $1,569.40 |
DisclosureSEC source: 0001019231-24-000022 · primary_doc.xml · nonDerivative · entry 12 UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO · CIK 0001019231 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,794,291 F1 · ownership.direct: Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the "Regents"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents. Read SEC document |
| May 01, 2024 Filed May 1, 2024 23:15 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | SaleCommon Stock | 1,750 | $4.12 | $7,210.00 |
DisclosureSEC source: 0001019231-24-000022 · primary_doc.xml · nonDerivative · entry 11 UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO · CIK 0001019231 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,794,671 F1 · ownership.direct: Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the "Regents"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents. Read SEC document |
| May 01, 2024 Filed May 1, 2024 23:15 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | SaleCommon Stock | 100 | $4.11 | $411.00 |
DisclosureSEC source: 0001019231-24-000022 · primary_doc.xml · nonDerivative · entry 10 UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO · CIK 0001019231 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,796,421 F1 · ownership.direct: Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the "Regents"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents. Read SEC document |
| May 01, 2024 Filed May 1, 2024 23:15 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | SaleCommon Stock | 3,100 | $4.10 | $12,710.00 |
DisclosureSEC source: 0001019231-24-000022 · primary_doc.xml · nonDerivative · entry 9 UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO · CIK 0001019231 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,796,521 F1 · ownership.direct: Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the "Regents"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents. Read SEC document |
| May 01, 2024 Filed May 14, 2024 21:54 UTC Amendment | Rein Therapeutics, Inc. ALRN · Entity 7071 | SaleCommon Stock | 25 | $4.32 | $108.00 |
DisclosureSEC source: 0001019231-24-000023 · primary_doc.xml · nonDerivative · entry 16 UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO · CIK 0001019231 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,790,142 F1 · ownership.direct: Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the "Regents"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents. Read SEC document |
| May 01, 2024 Filed May 14, 2024 21:54 UTC Amendment | Rein Therapeutics, Inc. ALRN · Entity 7071 | SaleCommon Stock | 2,903 | $4.29 | $12,453.87 |
DisclosureSEC source: 0001019231-24-000023 · primary_doc.xml · nonDerivative · entry 15 UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO · CIK 0001019231 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,790,167 F1 · ownership.direct: Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the "Regents"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents. Read SEC document |
| May 01, 2024 Filed May 14, 2024 21:54 UTC Amendment | Rein Therapeutics, Inc. ALRN · Entity 7071 | SaleCommon Stock | 200 | $4.29 | $857.00 |
DisclosureSEC source: 0001019231-24-000023 · primary_doc.xml · nonDerivative · entry 14 UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO · CIK 0001019231 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,793,070 F1 · ownership.direct: Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the "Regents"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents. Read SEC document |
| May 01, 2024 Filed May 14, 2024 21:54 UTC Amendment | Rein Therapeutics, Inc. ALRN · Entity 7071 | SaleCommon Stock | 337 | $4.28 | $1,442.36 |
DisclosureSEC source: 0001019231-24-000023 · primary_doc.xml · nonDerivative · entry 13 UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO · CIK 0001019231 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,793,270 F1 · ownership.direct: Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the "Regents"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents. Read SEC document |
| May 01, 2024 Filed May 14, 2024 21:54 UTC Amendment | Rein Therapeutics, Inc. ALRN · Entity 7071 | SaleCommon Stock | 200 | $4.28 | $855.00 |
DisclosureSEC source: 0001019231-24-000023 · primary_doc.xml · nonDerivative · entry 12 UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO · CIK 0001019231 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,793,607 F1 · ownership.direct: Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the "Regents"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents. Read SEC document |
| May 01, 2024 Filed May 14, 2024 21:54 UTC Amendment | Rein Therapeutics, Inc. ALRN · Entity 7071 | SaleCommon Stock | 100 | $4.27 | $427.00 |
DisclosureSEC source: 0001019231-24-000023 · primary_doc.xml · nonDerivative · entry 11 UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO · CIK 0001019231 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,793,807 F1 · ownership.direct: Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the "Regents"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents. Read SEC document |
| May 01, 2024 Filed May 14, 2024 21:54 UTC Amendment | Rein Therapeutics, Inc. ALRN · Entity 7071 | SaleCommon Stock | 317 | $4.27 | $1,352.01 |
DisclosureSEC source: 0001019231-24-000023 · primary_doc.xml · nonDerivative · entry 10 UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO · CIK 0001019231 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,793,907 F1 · ownership.direct: Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the "Regents"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents. Read SEC document |
| May 01, 2024 Filed May 14, 2024 21:54 UTC Amendment | Rein Therapeutics, Inc. ALRN · Entity 7071 | SaleCommon Stock | 310 | $4.26 | $1,320.60 |
DisclosureSEC source: 0001019231-24-000023 · primary_doc.xml · nonDerivative · entry 9 UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO · CIK 0001019231 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,794,224 F1 · ownership.direct: Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the "Regents"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents. Read SEC document |
| May 01, 2024 Filed May 14, 2024 21:54 UTC Amendment | Rein Therapeutics, Inc. ALRN · Entity 7071 | SaleCommon Stock | 7,923 | $4.25 | $33,672.75 |
DisclosureSEC source: 0001019231-24-000023 · primary_doc.xml · nonDerivative · entry 8 UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO · CIK 0001019231 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,794,534 F1 · ownership.direct: Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the "Regents"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents. Read SEC document |
| May 01, 2024 Filed May 14, 2024 21:54 UTC Amendment | Rein Therapeutics, Inc. ALRN · Entity 7071 | SaleCommon Stock | 400 | $4.18 | $1,672.00 |
DisclosureSEC source: 0001019231-24-000023 · primary_doc.xml · nonDerivative · entry 7 UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO · CIK 0001019231 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,802,457 F1 · ownership.direct: Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the "Regents"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents. Read SEC document |
| May 01, 2024 Filed May 14, 2024 21:54 UTC Amendment | Rein Therapeutics, Inc. ALRN · Entity 7071 | SaleCommon Stock | 670 | $4.15 | $2,780.50 |
DisclosureSEC source: 0001019231-24-000023 · primary_doc.xml · nonDerivative · entry 6 UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO · CIK 0001019231 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,802,857 F1 · ownership.direct: Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the "Regents"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents. Read SEC document |
| May 01, 2024 Filed May 14, 2024 21:54 UTC Amendment | Rein Therapeutics, Inc. ALRN · Entity 7071 | SaleCommon Stock | 1,600 | $4.15 | $6,632.00 |
DisclosureSEC source: 0001019231-24-000023 · primary_doc.xml · nonDerivative · entry 5 UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO · CIK 0001019231 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,803,527 F1 · ownership.direct: Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the "Regents"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents. Read SEC document |
| May 01, 2024 Filed May 14, 2024 21:54 UTC Amendment | Rein Therapeutics, Inc. ALRN · Entity 7071 | SaleCommon Stock | 380 | $4.13 | $1,569.40 |
DisclosureSEC source: 0001019231-24-000023 · primary_doc.xml · nonDerivative · entry 4 UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO · CIK 0001019231 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,805,127 F1 · ownership.direct: Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the "Regents"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents. Read SEC document |
| May 01, 2024 Filed May 14, 2024 21:54 UTC Amendment | Rein Therapeutics, Inc. ALRN · Entity 7071 | SaleCommon Stock | 1,750 | $4.12 | $7,210.00 |
DisclosureSEC source: 0001019231-24-000023 · primary_doc.xml · nonDerivative · entry 3 UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO · CIK 0001019231 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,805,507 F1 · ownership.direct: Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the "Regents"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.